Cipla | CIPLA - Ebitda

Aktienkurs
1,229.50
Täglich Wechseln
5.10 0.42%
Monatlich
-7.52%
Jährlich
-15.96%
Q2 Prognose
1,202.94




Ebitda Veränderung Datum
Arca Biopharma USD -25.07M 5.23M 2025-03
aTyr Pharma USD 25.85M 52.43M 2025-12
Bio Path USD -3.21M 631K 2025-03
Brainstorm Cell Therapeutics USD -3.04M 99K 2025-03
Capricor Therapeutics USD -27.23M 2.66M 2025-06
Cara Therapeutics USD -2.39M 3.16M 2025-03
Cipla INR 12.55B 6.4B 2025-12
Dr.Reddys Laboratories INR 20.89B 117M 2025-12
Esperion Therapeutics USD -9.93M 24.99M 2025-09
Immunic USD -22.78M 753K 2024-06
Infinity Pharmaceuticals USD -10.01M 1.39M 2023-06
Minerva Neurosciences USD -4.36M 1.71M 2024-09
Nektar Therapeutics USD -31.81M 70K 2023-09
Sun Pharmaceuticals INR 49.48B 8.52B 2025-12
TherapeuticsMD USD -1.64M 700K 2023-09
UPL INR 23.17B 1.12B 2025-12